Natalia Kurowska

Ms. Natalia Kurowska

Medical University of Silesia, Katowice, Śląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MMMarcel Madej
Marcel Madej
NKNatalia Kurowska
Natalia Kurowska
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
The increase in cancer cases is undoubtedly affecting the development of new therapeutic approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size, the possibility of incorporating into them medicinal substances and the ease with which their physicochemical properties may be manipulated, they are being used as anticancer drug delivery systems. The aim of this review is to focus on the use of nanoscale polymeric particles in the treatment of colorectal cancer, breast cancer, ovarian cancer and glioblastoma multiforme, and to consider their potential use in cancer gene therapy. According to several reports, the use of polymer nanoparticles as drug carriers is promising in solid tumors. With their application, it is possible to precisely deliver medicinal substances to the tumor structure, to overcome the blood–brain barrier in the case of brain tumors, to reduce the side effects of anticancer agents on normal cells and to achieve a therapeutic effect with a lower drug dose. Additionally, a number of reports indicate that they can also be used in combination with other methods of cancer treatment, mainly radiotherapy.

Verified
Journal Article
Open access
PDF file
NKNatalia Kurowska
Natalia Kurowska
MMMarcel Madej
Marcel Madej
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and is responsible for approximately one million deaths each year. The current standard of care is surgical resection of the lesion and chemotherapy with 5-fluorouracil (5-FU). However, of concern is the increasing incidence in an increasingly younger patient population and the ability of CRC cells to develop resistance to 5-FU. In this review, we discuss the effects of thymoquinone (TQ), one of the main bioactive components of Nigella sativa seeds, on CRC, with a particular focus on the use of TQ in combination therapy with other chemotherapeutic agents. TQ exhibits anti-CRC activity by inducing a proapoptotic effect and inhibiting proliferation, primarily through its effect on the regulation of signaling pathways crucial for tumor progression and oxidative stress. TQ can be used synergistically with chemotherapeutic agents to enhance their anticancer effects and to influence the expression of signaling pathways and other genes important in cancer development. These data appear to be most relevant for co-treatment with 5-FU. We believe that TQ is a suitable candidate for consideration in the chemoprevention and adjuvant therapy for CRC, but further studies, including clinical trials, are needed to confirm its safety and efficacy in the treatment of cancer.

Verified
Journal Article
Open access
PDF file
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
MMMarcel Madej
Marcel Madej
NKNatalia Kurowska
Natalia Kurowska
CKCelina Kruszniewska-Rajs
Celina Kruszniewska-Rajs
MKMagdalena Kimsa
Magdalena Kimsa
JGJoanna Magdalena Gola
Joanna Magdalena Gola
Retinal pigment epithelium (RPE) is a specialized structure essential for proper vision, which is constantly exposed to oxidative damage. With aging, this damage accumulates within the RPE cells, causing various diseases, including age-related macular degeneration (AMD). Numerous antioxidant substances are used to prevent this process in humans, including lutein. This study aims to determine the differences in the expression patterns of pyroptosis genes in senescent human retinal pigment epithelial cell line ARPE-19 exposed to lutein. Changes in the expression of pyroptosis-related genes were assessed by oligonucleotide microarrays, and the results were validated by real-time RT-qPCR. The microarray analysis showed seven transcripts were differentially expressed both in the H2O2-treated cells versus the controls and in the lutein/H2O2-treated cells compared to the H2O2-treated cells (FC > 2.0). Depending on the used lutein, H2O2, or co-treatment of ARPE-19 cells, statistically significant differences in the expression of TXNIP, CXCL8, BAX, and CASP1 genes were confirmed by the RT-qPCR (p < 0.05). A STRING database analysis showed that the proteins encoded by the analyzed genes form a strong interaction network (p < 0.001). These data indicate that lutein modulates the expression level of pyroptosis-related genes, which may be useful for the development of new methods preventing pyroptosis pathway activation in the future.

8 April 2022 in Cancers
Verified
Journal Article
Open access
PDF file
NKNatalia Kurowska
Natalia Kurowska
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
MMMarcel Madej
Marcel Madej
KPKlaudia Pająk
Klaudia Pająk
CKCelina Kruszniewska-Rajs
Celina Kruszniewska-Rajs
JGJoanna Gola
Joanna Gola
Genes associated with the TGFβ isoforms are involved in a number of different cancers, and their effect on the progression of brain tumors is also being discussed. Using an oligonucleotide microarray method, we assessed differences in expression patterns of genes in astrocytic brain tumor sections from 43 patients at different stages of disease. Quantitative mRNA assessment of the three TGFβ isoforms was also performed by real-time RT-qPCR. Oligonucleotide microarray data were analyzed using the PL-Grid Infrastructure. The microarray analysis showed a statistically significant (p < 0.05) increase in TGFβ1 and TGFβ2 expression in G3/G4 stage relative to G2, whereas real-time RT-qPCR validation confirmed this change only for the TGFβ2 isoform (p < 0.05). The oligonucleotide microarray method allowed the identification of 16 differential genes associated with TGFβ isoforms. Analysis of the STRING database showed that the proteins encoded by the analyzed genes form a strong interaction network (p < 0.001), and a significant number of proteins are involved in carcinogenesis. Differences in expression patterns of transcripts associated with TGFβ isoforms confirm that they play a role in astrocytic brain tumor transformation. Quantitative assessment of TGFβ2 mRNA may be a valuable method to complement the diagnostic process in the future.

2 February 2026 in Molecules
Verified
Journal Article
Open access
PDF file
NKNatalia Kurowska
Natalia Kurowska
MKMaria Książęk
Maria Książęk
PBPaulina Borkowska
Paulina Borkowska
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with resistance to 5-fluorouracil (5-FU) representing a major therapeutic challenge. Thymoquinone (TQ), a bioactive constituent of Nigella sativa, exhibits anticancer activity; however, the mechanisms underlying TQ-induced cell death appear to be highly context dependent. This study aimed to characterize cell line-specific death pathways triggered by TQ in colorectal cancer models with distinct molecular backgrounds and differential responsiveness to 5-FU. Human CRC cell lines RKO (5-FU-sensitive) and SW1116 (poorly responsive), along with normal colon epithelial cells (CCD-841CoN), were treated with TQ, 5-FU, or their combination for 24 h. Cell viability, DNA fragmentation, caspase-3/7, -8, and -9 activity, cell death phenotypes, and expression of apoptosis- and necroptosis-related genes were evaluated using MTT assays, ELISA, luminescent assays, flow cytometry, and RT-qPCR. TQ significantly reduced viability in both CRC cell lines while exerting minimal cytotoxicity toward normal cells. In RKO cells, characterized by microsatellite instability (MSI), TQ induced DNA fragmentation, caspase activation, and transcriptional upregulation of pro-apoptotic genes, consistent with apoptosis-associated signaling. In contrast, SW1116 cells, which exhibit chromosomal instability (CIN) and reduced responsiveness to 5-FU, displayed decreased viability accompanied by suppressed caspase activity and predominant features of caspase-independent necrotic cell death. This differential response may be attributed to the CIN phenotype, which has been associated with impaired apoptotic signaling and enhanced tolerance to cytotoxic stress. Combined TQ and 5-FU treatment did not produce synergistic cytotoxicity, as confirmed by Bliss independence analysis, but revealed distinct, cell line-dependent death programs. These findings demonstrate that TQ modulates cell death execution in a molecular context-dependent manner rather than enhancing 5-FU efficacy through pharmacological synergy.

13 August 2026 in Farmacja Polska
Verified
Journal Article
Open access
MLMaria Lesik
Maria Lesik
KKKatarzyna Weronika Kucińska
Katarzyna Weronika Kucińska
NKNatalia Kurowska
Natalia Kurowska
BSBarbara Strzalka-Mrozik
Barbara Strzalka-Mrozik
Przedmiot badań: Praca dotyczy analizy wpływu wybranych związków pochodzenia naturalnego: galusanu epigallokatechiny (EGCG), antocyjanów, resweratrolu oraz diosgeniny na procesy nowotworzenia w obrębie jelita grubego, ze szczególnym uwzględnieniem mechanizmów molekularnych istotnych dla prewencji i wspomagania leczenia raka jelita grubego. Cel pracy: to syntetyczne przedstawienie właściwości biologicznych wymienionych związków, ich molekularnych mechanizmów działania, wpływu na komórki raka jelita grubego oraz możliwych implikacji farmakoterapeutycznych, ze szczególnym uwzględnieniem terapii skojarzonej. Metodyka wyszukiwania i doboru literatury: została przeprowadzona na podstawie publikacji naukowych dostępnych w bazach PubMed, Scopus oraz Google Scholar. Informacje dotyczące badań klinicznych pozyskano z bazy ClinicalTrials.gov. Wyszukiwanie obejmowało publikacje dotyczące raka jelita grubego oraz galusanu epigallokatechiny (EGCG), antocyjanów, resweratrolu i diosgeniny. Wyszukiwanie literatury zakończono 10 maja 2026 roku. Zastosowano słowa kluczowe oraz ich kombinacje w języku polskim i angielskim, takie jak: „colorectal cancer”, „epigallocatechin gallate”, „EGCG”, „anthocyanins”, „resveratrol” oraz „diosgenin”. Do analizy włączono badania eksperymentalne in vitro, badania in vivo na modelach zwierzęcych oraz dostępne badania kliniczne. Wykluczono prace przeglądowe oraz publikacje niezwiązane bezpośrednio z rakiem jelita grubego. Łącznie zidentyfikowano 624 publikacje, z których po usunięciu duplikatów i analizie zgodności z kryteriami włączenia do końcowej analizy zakwalifikowano 56 publikacji. Wyniki: Analiza piśmiennictwa wykazała, że omawiane związki oddziałują na kluczowe procesy komórkowe i molekularne, takie jak regulacja cyklu komórkowego, indukcja apoptozy, stres oksydacyjny oraz ekspresja genów zaangażowanych w kancerogenezę. W badaniach przedklinicznych wykazano synergistyczne interakcje niektórych z tych substancji z konwencjonalnymi lekami przeciwnowotworowymi, w tym irynotekanem i oksaliplatyną. Najlepiej udokumentowane dane dotyczą EGCG, który wykazywał zdolność do selektywnej indukcji apoptozy komórek nowotworowych. Antocyjany modulowały szlaki związane z apoptozą i stanem zapalnym, resweratrol oddziaływał na różne etapy kancerogenezy mimo ograniczonej biodostępności, natomiast diosgenina hamowała proliferację komórek nowotworowych poprzez wpływ na cykl komórkowy i szlaki sygnałowe. Wnioski: Związki pochodzenia naturalnego mogą potencjalnie wspierać strategie prewencyjne i terapię wspomagającą raka jelita grubego, szczególnie jako adiuwanty terapii konwencjonalnej. Ich potencjalne zastosowanie kliniczne ogranicza jednak niewielka liczba badań z udziałem ludzi oraz problemy związane z biodostępnością i standaryzacją. Konieczne są dalsze badania kliniczne w celu oceny skuteczności i bezpieczeństwa długoterminowego stosowania tych związków w farmakoterapii raka jelita grubego.